It is primarily classified into three categories: primary non-hyperphosphatemic TC, associated with abnormalities in the SAMD9 gene) [9]; primary hyperphosphatemic TC, stemming from mutations in the FGF-23 gene [10]; and secondary TC, predominantly linked to CKD [11]. This evidence concerns the gene SAMD9 and chronic kidney disease.